SOMERSET, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) — MTBC (NASDAQ:MTBC) (NASDAQ:MTBCP), a leading provider of mHealth and cloud-based clinical and practice management solutions, today announced the successful full launch of its next-generation, voice-enabled electronic health records (EHR) solution, talkEHR™.

“The response from physicians during the first 30 days of our full rollout is overwhelming and confirms our belief in the market opportunity for a free, voice and AI driven EHR such as talkEHR,” said Karl Johnson, MTBC SVP Sales and Marketing. He continued, “We’re very pleased to have already signed new talkEHR clients representing 30 unique specialties, spanning across 42 states plus Guam and Puerto Rico.  talkEHR is a phenomenal addition to our fully integrated, industry leading, cloud-based and mobile platform and we expect it to play an important role as we continue to expand our customer base.”

talkEHR – MTBC’s next generation SaaS EHR solution – is designed to utilize natural language processing and artificial intelligence to automate key components of patient charting and reduce manual tasks and errors. It is an all-in-one, easy-to-use and easy-to-implement clinical platform that also includes value added solutions such as electronic claims submission, electronic prescriptions, appointment scheduling, automated patient reminders and quality incentive support.

talkEHR is being offered completely free of cost to all US healthcare providers.  talkEHR users can also upgrade to a full-service package that includes end-to-end medical billing for 2.95% of a physician’s collections.

Healthcare providers interested in learning more can visit

About MTBC

MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”

For additional information, please visit our website at


talkEHR™ is a trademark of MTBC.

Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “goals”, “intend”, “likely”, “may”, “plan”, “potential”, “predict”, “project”, “will” or the negative of these terms or other similar terms and phrases.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.

Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include, but are not limited to, the company’s ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward-looking statements contained in this press release are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.


Company and Investor Contact:
Bill Korn
Chief Financial Officer
Medical Transcription Billing, Corp.
(732) 873-5133

Primary Logo